Byng, D.; Retèl, V.P.; Engelhardt, E.G.; Groothuis-Oudshoorn, C.G.M.; van Til, J.A.; Schmitz, R.S.J.M.; van Duijnhoven, F.; Wesseling, J.; Bleiker, E.; van Harten, W.H.;
et al. Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists. Cancers 2021, 13, 3962.
https://doi.org/10.3390/cancers13163962
AMA Style
Byng D, Retèl VP, Engelhardt EG, Groothuis-Oudshoorn CGM, van Til JA, Schmitz RSJM, van Duijnhoven F, Wesseling J, Bleiker E, van Harten WH,
et al. Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists. Cancers. 2021; 13(16):3962.
https://doi.org/10.3390/cancers13163962
Chicago/Turabian Style
Byng, Danalyn, Valesca P. Retèl, Ellen G. Engelhardt, Catharina G. M. Groothuis-Oudshoorn, Janine A. van Til, Renée S. J. M. Schmitz, Frederieke van Duijnhoven, Jelle Wesseling, Eveline Bleiker, Wim H. van Harten,
and et al. 2021. "Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists" Cancers 13, no. 16: 3962.
https://doi.org/10.3390/cancers13163962
APA Style
Byng, D., Retèl, V. P., Engelhardt, E. G., Groothuis-Oudshoorn, C. G. M., van Til, J. A., Schmitz, R. S. J. M., van Duijnhoven, F., Wesseling, J., Bleiker, E., van Harten, W. H., & on behalf of the Grand Challenge Precision Consortium.
(2021). Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists. Cancers, 13(16), 3962.
https://doi.org/10.3390/cancers13163962